Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Clarkson

Showing results (121-130 of 235) with videos related to

Pageof 24
Sort By:
Cancer Research|March 1, 1975
Treatment of acute lymphoblastic leukemia in childreq with "prophylactic" intrathecal methotrexate and intensive systemic chemotherapyM Haghbin, C T Tan, B D Clarkson, et al.
Transfusion|January 1, 1982
A prospective study of platelet-transfusion therapy administered to patients with acute leukemiaJ Kutti, C G Zaroulis, R E Dinsmore, et al.
Cancer Genetics and Cytogenetics|September 1, 1983
Non-T, non-B acute lymphoblastic leukemia (L3) with t(8;22) and two 14q+ chromosomesR S Chaganti, S C Jhanwar, Z Arlin, et al.
The American Journal of Medicine|February 1, 1987
Non-Hodgkin's lymphomas: characteristics of long-term survivors following conservative treatmentD J Straus, J J Gaynor, P H Leiberman, et al.
Blood|September 1, 1982
Analysis of T-cell differentiation antigens in acute lymphatic leukemia using monoclonal antibodiesB Koziner, D Gebhard, T Denny, et al.
Journal of Biological Response Modifiers|October 1, 1984
Treatment of immunodeficiency with interleukin-2: initial explorationR Mertelsmann, K Welte, C Sternberg, et al.
Cancer|December 1, 1985
Hairy cell leukemia. Durability of response to splenectomy in 26 patients and treatment of relapse with androgens in six patientsM J Magee, S McKenzie, D A Filippa, et al.
Cancer Investigation|January 1, 1989
In vitro chemosensitivity of two Ewing's sarcoma cell lines: implication for autologous bone marrow transplantationS C Gulati, J H Kwon, J Atzpodien, et al.
The American Journal of Medicine|September 1, 1986
Evaluation of malignant lymphomas using three classifications and the working formulation. 482 cases with median follow-up of 11.9 yearsP H Lieberman, D A Filippa, D J Straus, et al.
Acta Haematologica|January 1, 1988
Cell-mediated toxicity of interleukin-2-activated lymphocytes against autologous and allogeneic human myeloma cellsC Shimazaki, J Atzpodien, D Wisniewski, et al.
Pageof 24

Showing results (121-130 of 235) with videos related to

Sort By:
Pageof 24
Cancer Research|March 1, 1975
Treatment of acute lymphoblastic leukemia in childreq with "prophylactic" intrathecal methotrexate and intensive systemic chemotherapyM Haghbin, C T Tan, B D Clarkson, et al.
Transfusion|January 1, 1982
A prospective study of platelet-transfusion therapy administered to patients with acute leukemiaJ Kutti, C G Zaroulis, R E Dinsmore, et al.
Cancer Genetics and Cytogenetics|September 1, 1983
Non-T, non-B acute lymphoblastic leukemia (L3) with t(8;22) and two 14q+ chromosomesR S Chaganti, S C Jhanwar, Z Arlin, et al.
The American Journal of Medicine|February 1, 1987
Non-Hodgkin's lymphomas: characteristics of long-term survivors following conservative treatmentD J Straus, J J Gaynor, P H Leiberman, et al.
Blood|September 1, 1982
Analysis of T-cell differentiation antigens in acute lymphatic leukemia using monoclonal antibodiesB Koziner, D Gebhard, T Denny, et al.
Journal of Biological Response Modifiers|October 1, 1984
Treatment of immunodeficiency with interleukin-2: initial explorationR Mertelsmann, K Welte, C Sternberg, et al.
Cancer|December 1, 1985
Hairy cell leukemia. Durability of response to splenectomy in 26 patients and treatment of relapse with androgens in six patientsM J Magee, S McKenzie, D A Filippa, et al.
Cancer Investigation|January 1, 1989
In vitro chemosensitivity of two Ewing's sarcoma cell lines: implication for autologous bone marrow transplantationS C Gulati, J H Kwon, J Atzpodien, et al.
The American Journal of Medicine|September 1, 1986
Evaluation of malignant lymphomas using three classifications and the working formulation. 482 cases with median follow-up of 11.9 yearsP H Lieberman, D A Filippa, D J Straus, et al.
Acta Haematologica|January 1, 1988
Cell-mediated toxicity of interleukin-2-activated lymphocytes against autologous and allogeneic human myeloma cellsC Shimazaki, J Atzpodien, D Wisniewski, et al.
Pageof 24